The Indian beauty and personal care market, a vibrant canvas of traditional brands, direct-to-consumer disruptors, and global entrants, is witnessing unprecedented growth. Yet, behind every successful product launch and viral trend lies a complex, often unseen, ecosystem of manufacturing and supply chain partners. It is in this crucial, high-stakes segment that Naturis Cosmetics, an R&D-led contract development and manufacturing organization (CDMO), has carved out a formidable niche. The company has now announced a significant milestone, raising Rs 100 crore in its maiden institutional funding round, a clear signal of investor confidence in the foundational infrastructure powering India’s consumption story. This capital infusion is set to propel Naturis into its next phase of expansion, solidifying its position as a preferred manufacturing partner for a diverse clientele ranging from burgeoning D2C labels to established pharmaceutical giants.
About Naturis Cosmetics: The Backbone of India’s Beauty Boom
Founded with a vision to be an R&D-driven contract development and manufacturing organization, Naturis Cosmetics specializes in creating and producing beauty, personal care, and over-the-counter (OTC) cosmeceutical products. In an industry where innovation and quality are paramount, Naturis distinguishes itself by integrating deep scientific expertise with agile manufacturing capabilities. This approach allows them to serve a broad spectrum of clients, including over 50 prominent beauty and personal care brands such as Nykaa, Pilgrim, Purplle, Colorbar, Bare Anatomy, Kay Beauty, and Asaya. Their robust capabilities also extend to partnering with pharmaceutical firms like Glenmark and Dr. Reddy’s Laboratories for their OTC and specialized cosmeceutical segments, a testament to their stringent quality control and formulation prowess.
Under the leadership of co-founder and CEO Rahul Tandon, Naturis has demonstrated impressive financial resilience and growth. The company has consistently remained profitable, a rare feat in the often capital-intensive manufacturing sector. In the fiscal year 2025, Naturis Cosmetics reported operating revenue of Rs 154 crore, marking a substantial approximately 40% increase from Rs 110 crore in the preceding fiscal year. During the same period, the company recorded a profit of Rs 12 crore. This strong performance isn’t an anomaly; Naturis has sustained a revenue growth of over 50% compound annual growth rate (CAGR) for the past four years, highlighting its robust business model and increasing demand for its services. This trajectory underscores the critical role played by sophisticated CDMOs in enabling brands to scale efficiently without the burden of heavy capital expenditure on their own manufacturing units.
The Landmark Funding Deal
Naturis Cosmetics has successfully closed its maiden institutional funding round, securing Rs 100 crore. This significant equity investment was led by Sharrp Ventures, the family office of Marico Limited’s promoters, a strategic investor with deep roots and unparalleled insights into the consumer goods sector.
The round also saw robust participation from a diverse group of co-investors, each bringing strategic value and confidence to Naturis’s growth story. These included Mirabilis Investment Trust, the family office of Infosys co-founder K. Dinesh, known for its discerning eye for strong business fundamentals and long-term potential. Anicut Capital, a prominent alternative investment fund, also joined the round, signaling its belief in Naturis’s market leadership and scalability. Further support came from Niveshaay, Hyperscale Ventures founder Suyash Saraf, Yogesh Kabra, and a consortium of angel investors with backgrounds in the pharmaceutical and specialty chemicals sectors. This diverse investor base, comprising strategic family offices, growth equity funds, and industry veterans, not only provides capital but also invaluable mentorship and network access.
Sharrp Ventures’ decision to lead this round is particularly noteworthy. Given their extensive experience in the fast-moving consumer goods (FMCG) industry through Marico, they possess an intimate understanding of the complexities of product development, supply chain management, and quality control. Their investment in Naturis underlines a strong belief in the company’s R&D capabilities and its crucial role in serving both established and emerging consumer brands. For Mirabilis Investment Trust, the investment likely reflects a conviction in Naturis’s profitable growth trajectory and its potential to become a dominant player in India’s manufacturing ecosystem, a sector often overlooked but essential for economic expansion. The participation of investors from the pharma and specialty chemicals sectors further validates Naturis’s technical expertise and its ability to meet the stringent quality and regulatory requirements across diverse product categories.
Strategic Deployment of Fresh Capital
The Rs 100 crore capital infusion is earmarked for a comprehensive expansion strategy designed to significantly enhance Naturis Cosmetics’ operational footprint and technological capabilities. The funds will be strategically deployed across several key areas to meet the escalating demand from its growing client base and to fortify its competitive edge.
A significant portion of the capital will be channeled into expanding manufacturing capacity. This includes the establishment of a brand new, state-of-the-art manufacturing facility in Vapi, a strategically located industrial hub. This expansion is critical for Naturis to scale production volumes, introduce new product lines, and optimize operational efficiencies. Alongside manufacturing, the company plans to strengthen its core R&D capabilities. This will involve setting up an advanced R&D hub in Mumbai, a move that will allow Naturis to push the boundaries of formulation science, develop innovative ingredients, and offer more bespoke solutions to its clients.
Furthermore, Naturis intends to establish an experience centre in the National Capital Region (NCR). This initiative will likely serve as a dynamic interface for clients, allowing them to collaborate more closely on product development, explore new textures and ingredients, and witness Naturis’s capabilities firsthand. The capital will also enable Naturis to strategically expand into new beauty, personal care, and OTC categories, diversifying its product portfolio and tapping into emerging market trends.
Rahul Tandon, co-founder and CEO of Naturis Cosmetics, articulated the company’s vision, stating that the funding will empower Naturis to “strengthen its R&D capabilities, expand manufacturing capacity, and accelerate its vision of building a leading beauty and personal care manufacturing platform in India.” This statement clearly outlines the dual focus on technological innovation and scaled production, positioning Naturis at the forefront of India’s rapidly evolving consumer landscape.
Market Opportunity: Riding the Wave of India’s Consumption Story
The Indian beauty and personal care market is currently experiencing a phenomenal surge, projected to reach substantial valuations in the coming years. This growth is fueled by a confluence of factors: rising disposable incomes, increasing awareness of personal grooming, the rapid proliferation of direct-to-consumer (D2C) brands, and a demographic dividend of young, digitally-savvy consumers. While brands capture headlines, the underlying infrastructure, particularly sophisticated contract manufacturing, is the unsung hero enabling this revolution.
Naturis Cosmetics operates at the confluence of this dynamic market. The sheer volume of new beauty and personal care brands entering the market, coupled with the expansion of existing players, creates an immense demand for reliable, high-quality, and innovative manufacturing partners. For many brands, particularly D2C startups, investing in their own manufacturing units is capital-intensive and diverts focus from their core competencies of brand building, marketing, and distribution. This is where CDMOs like Naturis step in, offering a full suite of services from concept to commercialization, allowing brands to remain agile and asset-light.
The competitive landscape for contract manufacturing in India is fragmented, with numerous smaller players. However, Naturis distinguishes itself through its R&D-led approach, a diverse and premium client portfolio, and a proven track record of profitability and growth. Its ability to serve both niche D2C brands and large pharmaceutical companies speaks volumes about its versatility, quality standards, and adherence to complex regulatory frameworks. This dual capability, especially within the OTC and cosmeceuticals segments, provides a strong competitive moat, as it requires a higher degree of scientific rigor and compliance. The market opportunity for Naturis is not merely about producing more units; it is about becoming the innovation partner that helps brands differentiate themselves in a crowded marketplace.
What’s Next for Naturis Cosmetics
With the fresh capital infusion, Naturis Cosmetics is poised for an accelerated growth trajectory. The immediate milestones include the rapid development and commissioning of the new manufacturing facility in Vapi, which will significantly expand its production bandwidth and allow for the onboarding of new clients and larger orders. The establishment of the R&D hub in Mumbai is expected to foster deeper innovation, potentially leading to proprietary formulations and advanced ingredient development, further enhancing Naturis’s value proposition to its brand partners.
The experience centre in NCR will serve as a crucial touchpoint, strengthening client relationships and facilitating collaborative product development, ensuring Naturis remains at the cutting edge of market trends. Furthermore, the strategic expansion into new beauty, personal care, and OTC categories signifies a proactive approach to tapping into nascent market segments and diversifying revenue streams. This could involve exploring areas like specialized skincare, sustainable beauty products, or advanced nutraceuticals, aligning with global consumer shifts towards health and wellness.
As India’s consumer market continues its robust expansion, the reliance on sophisticated, quality-driven contract manufacturers will only intensify. Naturis Cosmetics, with its strong foundation, proven profitability, and strategic capital infusion, is exceptionally well-positioned to not only meet this demand but also to shape the future of manufacturing for India’s booming beauty and personal care ecosystem. The company’s journey forward will undoubtedly be a closely watched story in the Indian startup and manufacturing landscape.
